The standard tesamorelin dosage for visceral fat loss is 2 mg injected subcutaneously once daily, typically before bedtime, based on clinical trials and real-world use in Canada. This regimen targets the reduction of deep belly fat, especially in individuals with excess abdominal adiposity. Below, we break down the exact protocol, timing, and practical tips for Canadian users.
What Is Tesamorelin and How Does It Reduce Visceral Fat?
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to release growth hormone (GH), which in turn increases insulin-like growth factor-1 (IGF-1). This hormonal cascade promotes lipolysis, the breakdown of fat, particularly in visceral adipose tissue. Visceral fat is the metabolically active fat surrounding internal organs, linked to insulin resistance and cardiovascular risk. Unlike some weight-loss peptides that reduce overall body weight, tesamorelin specifically shrinks visceral fat while preserving lean mass. Clinical studies show a 15-20% reduction in visceral adipose tissue over 26 weeks of daily use.
Standard Tesamorelin Dosage Protocol
The FDA-approved and clinically studied dose is 2 mg per day. This is the dose used in the pivotal Phase 3 trials for HIV-associated lipodystrophy and is widely adopted for off-label visceral fat reduction. The injection is subcutaneous, meaning it goes into the fatty tissue just under the skin. Common injection sites include the abdomen, thigh, or upper arm. Rotate sites daily to avoid irritation. The timing of the injection matters: tesamorelin should be administered at least 30 minutes after the last meal of the day, ideally right before sleep. This mimics the body's natural GH pulse and may enhance fat-burning during sleep. Do not eat for at least 2 hours before injecting to avoid insulin spikes that can blunt GH release.
Reconstitution and Measurement
Tesamorelin typically comes as a lyophilized powder in vials of 1 mg or 2 mg. For a 2 mg vial, reconstitute with 1 mL of bacteriostatic water. This yields a concentration of 2 mg/mL, so drawing 1 mL (100 units on an insulin syringe) gives the full 2 mg dose. For a 1 mg vial, you would need two vials to reach the 2 mg dose, or you can reconstitute with 0.5 mL and draw the entire volume. Always use a new, sterile syringe and alcohol swab the vial top before and after. Store reconstituted tesamorelin in the refrigerator and use within 14 days. Unreconstituted powder can be kept in the freezer for longer-term storage.
Cycle Length and Duration
The typical cycle length is 6 months (26 weeks), mirroring the clinical trial duration. Some users extend to 12 months, but data on longer cycles is limited. After 6 months, a break of 4-8 weeks is common to reset receptor sensitivity. During the cycle, visceral fat reduction is usually noticeable by week 12, with maximum results around week 26. It is not a quick fix; patience and consistency are key. Cycling on and off may help maintain long-term effectiveness.
Maximizing Results: Diet and Exercise
Tesamorelin works best when combined with a calorie-controlled diet and regular exercise. While it directly targets visceral fat, a caloric surplus can offset its benefits. Aim for a modest deficit of 300-500 calories per day. Prioritize protein to support lean mass. Resistance training amplifies GH's anabolic effects, while cardio helps with overall fat oxidation. Avoid high-glycemic meals close to injection time. Some Canadian users pair tesamorelin with other peptides like ipamorelin for synergistic GH release, but this should be done under medical guidance.
Potential Side Effects and How to Manage Them
Common side effects include injection site reactions (redness, itching, swelling), joint pain, and muscle aches. These are usually mild and transient. More concerning is the potential for elevated blood sugar; tesamorelin can reduce insulin sensitivity. Monitor fasting glucose and HbA1c, especially if you are prediabetic. Some users experience water retention in the first few weeks, which can mask fat loss on the scale. This resolves as the body adapts. Rare but serious risks include allergic reactions and increased IGF-1 levels beyond the normal range, which could theoretically raise cancer risk. Always consult a healthcare provider before starting.
Tesamorelin vs Other Peptides for Visceral Fat
Compared to other peptides, tesamorelin has the strongest evidence for visceral fat reduction. For example, tesamorelin and tirzepatide differ in their mechanisms: tirzepatide is a GLP-1/GIP agonist that reduces overall weight, while tesamorelin specifically targets visceral fat via GH. AOD-9604 and HGH Fragment 176-191 also claim fat-burning properties, but clinical data is sparse. For those considering a combined approach, stacking tesamorelin with tirzepatide may offer complementary benefits, though research is ongoing. In Canada, access to these peptides varies, and tesamorelin remains a prescription-only medication.
Where to Buy Tesamorelin in Canada
Tesamorelin is available in Canada under the brand name Egrifta, primarily indicated for HIV-related lipodystrophy. It requires a prescription from a licensed physician. Some specialized clinics and telemedicine services offer off-label prescriptions for visceral fat reduction. Prices range from $800 to $1,200 CAD per month, depending on the pharmacy and insurance coverage. Research-grade tesamorelin is sold by online peptide vendors, but quality and purity are not guaranteed. If you choose this route, insist on third-party lab testing and read reviews carefully. For those in Quebec, sourcing peptides in Montreal follows similar cautionary principles. Always verify the legal status in your province.
Legal and Regulatory Considerations in Canada
In Canada, tesamorelin is a Schedule F prescription drug, meaning it cannot be sold without a prescription. Importing for personal use is a gray area; Health Canada permits a 90-day supply for personal use if prescribed by a foreign doctor, but this is rarely enforced. Buying from domestic sources without a prescription is illegal. Be wary of vendors claiming to sell "for research purposes only" as this is a common loophole that does not absolve the buyer of legal risk. Always prioritize safety and legality.
Frequently Asked Questions
Can I take tesamorelin if I am not HIV-positive?
Yes, many clinics prescribe it off-label for visceral fat reduction in non-HIV patients, especially those with metabolic syndrome or age-related abdominal fat. However, insurance coverage is unlikely without an HIV diagnosis.
How quickly will I see results?
Most users notice a reduction in waist circumference after 8-12 weeks. The full effect typically takes 6 months. Patience and adherence to the protocol are essential.
Do I need to cycle tesamorelin?
Cycling is not mandatory but is recommended to maintain effectiveness. A common pattern is 6 months on, 1-2 months off. Long-term continuous use may lead to diminished response.
Can women use tesamorelin?
Yes, the clinical trials included both men and women. Dosing is the same. Women of childbearing age should use contraception, as the effects on fetal development are unknown.
Is tesamorelin better than diet and exercise alone?
Tesamorelin provides an additional tool, but it is not a substitute. The best results come from combining the peptide with lifestyle changes. In studies, the placebo group (diet and exercise alone) lost some visceral fat, but the tesamorelin group lost significantly more.
Practical Tips for Canadian Users
If you are in Canada and considering tesamorelin, start with a thorough medical evaluation. Check your fasting insulin, glucose, and IGF-1 levels. Work with a doctor experienced in peptide therapies. Keep a log of your injections, diet, and measurements. Take progress photos and waist circumference measurements every two weeks. Be prepared for the cost; if insurance does not cover it, budget $800-$1,200 monthly. For those exploring other options, tirzepatide may also address weight and metabolic health, though its effect on visceral fat is less targeted. Remember that peptide therapies are not magic; they require commitment and a holistic approach.
Conclusion
The tesamorelin dosage for visceral fat loss is 2 mg daily, injected subcutaneously before bed, for at least 6 months. This regimen has strong clinical backing and can significantly reduce dangerous belly fat when combined with a healthy lifestyle. In Canada, access requires a prescription, and costs are high, but for those struggling with stubborn visceral adiposity, it may be a worthwhile option. Always prioritize safety, legality, and medical supervision.
The compounds named in this article are not approved for human therapeutic use in most jurisdictions.